Amitriptyline/chlordiazepoxide

Amitriptyline/chlordiazepoxide, sold under the brand names Limbitrol and Limbitrol DS, is a combination of amitriptyline (Elavil), a tricyclic antidepressant, and chlordiazepoxide (Librium), a benzodiazepine, which is approved for the treatment of moderate to severe depression associated with moderate to severe anxiety in the United States.[1][2] It contains 12.5 to 25 mg amitriptyline and 5 to 10 mg chlordiazepoxide per tablet.[1][2]

Amitriptyline/chlordiazepoxide
Amitriptyline (top) and chlordiazepoxide (bottom)
Combination of
AmitriptylineTricyclic antidepressant
ChlordiazepoxideBenzodiazepine
Clinical data
Trade namesLimbitrol, Limbitrol DS
Routes of
administration
Oral
Legal status
Legal status
  • In general: ℞ (Prescription only)

References

edit
  1. ^ a b Mylan Pharmaceuticals Inc. (May 2014). "Chlordiazepoxide and Amitriptyline Tablets Label" (PDF). U.S. Food and Drug Administration.
  2. ^ a b Townsend MC, Morgan KI (9 January 2018). Pocket Guide to Psychiatric Nursing. F.A. Davis. pp. 443–. ISBN 978-0-8036-7705-0. OCLC 1019871725.